Your browser doesn't support javascript.
loading
PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer.
Shen, Yang; Teng, Yongsheng; Lv, Yipin; Zhao, Yongliang; Qiu, Yuan; Chen, Weisan; Wang, Lina; Wang, Ying; Mao, Fangyuan; Cheng, Ping; Ma, Daiyuan; Zhuang, Yuan; Zou, Quanming; Peng, Liusheng.
Afiliação
  • Shen Y; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Teng Y; Department of oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.
  • Lv Y; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Zhao Y; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Qiu Y; Department of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Chen W; Department of General Surgery of Xinqiao Hospital, Third Military Medical University, Chongqing, China.
  • Wang L; La Trobe Institute for Molecular Science, School of Molecular Science, La Trobe University, Bundoora, Victoria, Australia.
  • Wang Y; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Mao F; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Cheng P; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Ma D; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Zhuang Y; Department of oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China pengliusheng06@163.com qmzou@tmmu.edu.cn yuanzhuang1983@yahoo.com mdylx@163.com.
  • Zou Q; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China pengliusheng06@163.com qmzou@tmmu.edu.cn yuanzhuang1983@yahoo.com mdylx@163.com.
  • Peng L; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China pengliusheng06@163.com qmzou@tmmu.edu.cn yuanzhuang1983@yahoo.com mdylx@163.com.
J Immunother Cancer ; 8(2)2020 08.
Article em En | MEDLINE | ID: mdl-32753468
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Linfócitos T CD8-Positivos / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Linfócitos T CD8-Positivos / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido